Intelligent Bio Solutions Inc. Unveils Non-Invasive Drug Testing Technology in Investor Presentation
Reuters
Dec 02
Intelligent Bio Solutions Inc. Unveils Non-Invasive Drug Testing Technology in Investor Presentation
Intelligent Bio Solutions Inc. has released a presentation detailing its advancements in drug testing technology. The company highlighted its Intelligent Fingerprinting Drug Screening System, which utilizes fingerprint sweat analysis to detect recent drug use. The system is designed to be non-invasive, portable, and efficient, with the capability to screen for substances such as opiates, cocaine, methamphetamine, and cannabis. According to the presentation, the process involves collecting fingerprint sweat samples, which are then analyzed to provide results in less than 10 minutes. The technology aims to reduce costs, improve testing efficiency, and enhance sample integrity while maintaining privacy and dignity for individuals being tested. You can access the full presentation through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief on December 02, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.